Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

RMI1 Inhibitors

RMI1 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of RMI1, a key component of the Bloom syndrome complex, also known as the BLM-Topo IIIα-RMI1-RMI2 complex. This protein complex plays a crucial role in maintaining genome stability by regulating DNA repair and recombination processes, particularly during homologous recombination and the resolution of DNA double-strand breaks. RMI1 functions as a scaffold protein, stabilizing the interactions between other members of the complex, such as the RecQ helicase BLM and topoisomerase IIIα. It is involved in dissolving recombination intermediates, ensuring proper DNA repair and preventing harmful chromosomal rearrangements. Inhibition of RMI1 disrupts its interaction with other proteins in this complex, potentially leading to impaired DNA repair mechanisms and altered genome stability.

The development of RMI1 inhibitors requires an understanding of the protein's structural features, particularly the domains that mediate its interactions with BLM and topoisomerase IIIα. These inhibitors typically target specific binding interfaces or regions of RMI1 that are essential for maintaining the integrity of the BLM complex. By blocking these interactions, RMI1 inhibitors prevent the proper assembly or function of the complex, affecting its ability to resolve DNA structures and maintain genomic stability. Structural biology techniques such as X-ray crystallography and molecular docking are often used to identify the key domains involved in these protein-protein interactions and to design inhibitors with high specificity for RMI1. Achieving specificity is critical, as many other proteins are involved in DNA repair pathways, and off-target inhibition could have unintended effects on other DNA repair processes. RMI1 inhibitors serve as valuable tools for studying the molecular mechanisms underlying genome maintenance and for exploring the intricate interactions between proteins involved in DNA recombination and repair.

SEE ALSO...

Items 11 to 14 of 14 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Mitoxantrone

65271-80-9sc-207888
100 mg
$285.00
8
(1)

Mitoxantrone might downregulate RMI1 through DNA intercalation and inhibition of topoisomerase II, which can lead to transcriptional repression of certain genes.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid could decrease RMI1 expression by binding to retinoic acid receptors that heterodimerize with repressor proteins at the RMI1 promoter site, silencing gene expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin could lead to a decrease in RMI1 levels by inhibiting the mTOR pathway, which is crucial for cell growth and protein synthesis, including the synthesis of RMI1.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide may reduce RMI1 protein synthesis by blocking the translocation step in eukaryotic translation, leading to decreased RMI1 levels.